Interactions between P-sel and the PSGL-1 mediate the earliest adhesive events during an inflammatory response. Human PSGL-1 displays a high degree of genetic polymorphism that has been diversely associated with susceptibility to human diseases. In the central part of PSGL-1, a 10-aa motif is repeated 14, 15, or 16 times. Moreover, two mutations, M62I and M274V, are often found giving the most common variant M62-M274 with 16 motifs (M16M) and its variants I62-M274 (I16M). Two other variants exist with 15 repeated motifs (M62-M274; M15M) and with 14 motifs (M62-V274; M14V). We investigated the potential difference in the adhesive properties between these natural variants stably expressed in the HEK cell line by using the BFP technique. Their interactions with P-sel were found to be of catch bond-type, and the dissociation force was primarily dependent on the number of decameric motifs: the shorter the PSGL-1, the larger the bond strength. Finally, we found that the M62I mutation, which is close to the binding site to P-sel, reduced the adhesiveness to P-sel effectively. Collectively, these data shed new light on the polymorphism of PSGL-1 and could help the research on its associations to human pathologies.
Introduction
Inflammatory response is a complex, multistep process that begins with the leukocyte adhesion cascade. Circulating white blood cells interact with activated endothelial cells in a first rolling step involving selectin molecules and their ligands, including P-sel and PSGL-1. P-sel is expressed by activated endothelium as well as activated platelets, whereas PSGL-1 is present mainly on leukocytes but has also been detected on endothelial cells and platelets [1, 2] . PSGL-1, also named CD162, was identified as a P-sel ligand through a functional screening in Cos cells transfected with a specific FT [3] but also proved to interact with E-selectin and L-selectin with lower affinities [4 -7] . This mucin-like transmembrane protein works as a homodimer of ϳ240 kDa in a calcium-dependent manner and requires intensive post-translational modifications, including fucosylation to bind P-sel [8 -11] . A soluble isoform of PSGL-1 has been observed [12] . As its ORF is fully located in a single exon, the circulating form is likely to result from the shedding of the native transmembrane protein by unidentified proteinases that might include ␤-secretase 1 [13] . A soluble rPSGL-1 protein is currently tested as a therapeutic tool to reduce chronic inflammation [14, 15] . Knockout mice invalidated for the gene encoding PSGL-1 have a delayed response to inflammatory signals, neutrophilia, and abnormal leukocyte rolling [16, 17] .
PSGL-1 is encoded by the SELPLG gene composed of two exons on chromosome 12 [18] . We and others [19, 20] have explored the genetic polymorphism of the SELPLG gene and described numerous variants affecting principally the coding region of the gene. In particular, frequent polymorphisms include a 10-aa-degenerated motif, repeated 14, 15, or 16 times (VNTR) and present in the central part of the protein, as well as missense polymorphisms M62I and S273F-M274V. We analyzed the distribution of the different alleles for these variants in a cohort of CAD patients and controls. A significant association between the M62I variant and increased plasma levels of PSGL-1 was found, whereas a lower number of the VNTR repeats was associated with lower PSGL-1 levels [20] . No association with the pathology was uncovered thus far. Other association studies have tried to establish links between SEL-PLG polymorphisms and various diseases, including cardiovascular disorders and multiple sclerosis, but with variable success [21] [22] [23] [24] [25] [26] [27] [28] .
The physical nature of the reversible bond between P-sel and PSGL-1 was subject to intensive study [29, 30] . To fit with the observed behavior, i.e., rolling of leukocytes in fast flow and preventing its arrest in slow flow, this bond should be null or very weak at low shear stress and be stronger at higher stress. It was hypothesized that this link was of a "catch bond"-type, i.e., with force-induced prolongation of lifetime [31] . Then, this was demonstrated directly by atomic force microscopy [32] , by analysis of flow adhesion behavior [33] , or using the BFP technique [34, 35] , which investigates the properties of a unique bimolecular bond under various loading rates [36, 37] .
This latter technique proved to be useful to compare numerous variants of the same molecules. We used it to compare the biophysical adhesive properties of the various variants of the PSGL-1 protein. We found that the number of the VNTR repeats was associated inversely with the strength of the adhesion to P-sel.
MATERIALS AND METHODS

PSGL-1 constructs
Plasmids pEA.3/4FT, coding for the 3/4FT and pMT21.PL85, carrying the human PSGL-1 cDNA, were generous gifts from Dr. Diane Sako (Genetics Institute-Wyeth Research, Cambridge, MA, USA) [3] . The latter served as a template for amplification of the PSGL-1 ORF with the proofreading enzyme Turbo Pfu (Stratagene, La Jolla, CA, USA) and with 5ЈPSGL1 and 3ЈPSGL1 primers (see Supplemental Table 1 ). After double digestion, the insert was religated in an EcoRI-and EcoRV-digested pTracer-EF(A) vector (Invitrogen, Paisley, UK). Sequencing of ampicillin-resistant clones was performed using the BigDye Terminator kit (Applied Biosystems, Courtaboeuf, France).
We identified a positive clone harboring the PSGL-1-coding region, fused in frame at its 3Ј extremity with a V5 epitope and a histidine stretch before the stop codon, which exhibited the perfect sequence of the original cDNA published by Sako et al. [3] . It served as a "master version" for the cloning of all other desired haplotypic versions and was named M15M, according to its genotype for polymorphisms M62I, number (14, 15, or 16) of repeats of the decameric motif, and M274V, respectively. The plasmid was then digested with SrfI and PpuMI to release a central 1154-bp cassette, and cassettes corresponding to the 1154-bp central part of the gene were amplified with primers box U and box L from genomic DNA of genotyped individuals carrying haplotypes chosen specifically. These fragments were digested with SrfI and PpuMI, gel-purified, and religated into the recipientopened master version plasmid. Complete sequencing of positive clones allowed the validation of the different haplotypic versions of the plasmid. By this approach, we could obtain plasmids M15M (master version), M16M, I16M, and M14V. Large amounts of plasmidic DNA were obtained with the MidiPrep plasmid kits (Qiagen, Courtaboeuf, France).
RT-PCR, PCR, cell culture, and transfection
HEK 293 cells were grown in high glucose DMEM, supplemented with 10% FCS (Eurobio, Courtaboeuf, France), 1 mM sodium pyruvate, 2 mM glutamine, and 100 U/ml penicillin streptomycin (Invitrogen). To generate stable transfectants, HEK cells were triply transfected (PolyFect reagent, Qiagen) with one of the constructs expressing the PSGL-1; the pEA.3/4FT plasmid expressing the 3/4FT, ensuring the correct post-translational modification of the PSGL-1 molecules in the HEK cell line; and pEYFP (Clontech, Palo Alto, CA, USA), expressing a fluorescent molecule to serve as a marker. Two days after, cells were placed in complete medium supplemented with 400 g/ml zeocin and 1 mg/ml geneticin (Invitrogen). After 10 days, an enrichment step on magnetic beads was performed (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). Triple transfectants were incubated with a mouse anti-human PSGL-1 antibody (PL1, Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 10 min at 4°C. The suspension was then incubated with magnetic beads coupled to a goat anti-mouse IgG antibody, as recommended by the manufacturer (Miltenyi Biotec GmbH) for 15 min at 4°C and then column-purified. After washing, released cells were grown for 2-4 weeks in selection medium and checked for the expression of the relevant molecules by RT-PCR, flow cytometry, and Western blotting.
RNA was extracted from cell pellets by the RNeasy kit (Qiagen) following the manufacturer's recommendations. Total RNA (2-5 g) was retrotranscribed using the Superscript II kit (Invitrogen). PCR conditions were 5 min at 95°C, followed by 35 cycles at 95°C for 30 s, a specific annealing temperature for 30 s, 72°C for 1 min, and a final 10-min step at 72°C. The amplifications were performed in a 50-l final volume with the Bioline Taq polymerase (Abcys, Paris, France) at the concentration of 5 U/l and recommended reagents. Primers for the amplification of PSGL-1 (PSGL-1 box U and L) and of the FT (pEA U and L; 3/4FT U and L) are described in Supplemental Table 1 .
Flow cytometry
Expression of PSGL-1 on HEK 293 cells and clones was tested with PE-labeled murine anti-PSGL-1 mAb (PL1-PE, Santa Cruz Biotechnology) and was analyzed by flow cytometry using a FACScan (Becton Dickinson, le Pont-de-Claix, France).
Western blot
Cell pellets were lysed in 50 mM Tris, pH 8, 1% Nonidet P-40, and 150 mM NaCl lysis buffer, complemented with 1 mM PMSF and anti-protease cocktail (Sigma-Aldrich, Lyon, France) for 30 min at 4°C. The samples were then assayed for protein content, diluted in sample loading buffer, and heated for 5 min at 95°C. Proteins were separated by 7.5% standard SDS-PAGE. Gels were transferred by a semi-dry (BioRad, Hercules, CA, USA) method onto an Invitrolon membrane (Invitrogen). Blots were probed with a polyclonal antibody against PSGL-1 (PL1, Santa Cruz Biotechnology), a monoclonal mouse anti-polyhistidine (R&D Systems, Minneapolis, MN, USA), or the sialyl-Lewis X -specific CHO-131 monoclonal (R&D Systems) and revealed with a secondary peroxidase-conjugated AffiniPure goat anti-mouse IgG (Jackson ImmunoResearch, West Grove, PA, USA). Final detection was obtained with the ECL Plus detection kit (GE Healthcare, Waukesha, WI, USA).
Static adhesion assay
A goat anti-human Fc antibody (Chemicon, El Segundo, CA, USA) was adsorbed for 2 h on Maxisorb 96-well plates at a 300 nM concentration. A recombinant human P-sel/Fc chimera (R&D Systems) was then added to adsorb overnight at 4°C (100 nM). Aliquots of 100,000 cells of the different final pools were loaded on the coated wells and left for 45 min to adhere at room temperature. An initial reading of the fluorescence was done at this time-point on a Packard Bioscience Fusion microplate analyzer (at 540Ϯ20 nm to detect EYFP). To remove non-adherent cells, the wells were filled gently with PBS, and the microplate was placed floating upside down for 1 h in a PBS solution before a final reading. After washing, the proportion of adherent cells was calculated as the ratio of the final reading to the initial reading. To take into account only the PSGL-1-positive cell fraction, this ratio was multiplied by the proportion of PSGL-1-positive cells measured by flow cytometry (see Fig. 1A ).
Force measurements with a BFP
The BFP method [36] uses a force transducer made of a biotinylated RBC maintained by a glass micropipette and with a streptavidin-coated glass microbead attached on its top. The RBC is used as a spring of known stiffness k, which is tuned by the controlled aspiration pressure applied by the holding micropipette. The streptavidin-coated glass bead can be decorated with molecules of interest (here, goat anti-human Fc antibodies and P-sel-Fc recombinant fusion protein), which will be displayed on the tip of the force transducer (see Fig. 3 , inset). The glass bead also enables precise video tracking, as when observed with a slightly unfocused, inverted optical microscope, it displays a light spot with a Gaussian intensity profile on its center.
The force measurements consist in approach-contact-retraction automated cycles of the BFP force transducer. During the approach phase, the force transducer is translated with constant speed into contact with PSGL-1-expressing HEK cells maintained by another micropipette facing the first one. The contact is ensured by an 80-pN compression force exerted on the force transducer (i.e., a compression of the RBC). The contact is held during 400 ms, and then, the retraction phase is initiated. If a bond has been formed between the BFP tip (the P-sel bead) and the facing cell surface during the contact, a force will be exerted on the force transducer. Reciprocally, the bond between the BFP tip and the cell will experience a force until it breaks. The force exerted on the bond between the BFP tip and the cell membrane during the retraction phase is a ramp, with a slope as the loading rate r. The force exerted on the bond is then F ϭ r.t, where t is the time, starting from the beginning of the retraction phase. The RBC membrane tension is set by the pipette aspiration pressure, which provides a direct control of the spring constant. The elongation of the RBC is obtained with an accuracy of a few nanometers.
Experiments were conducted in a chamber made of two glass coverslips facing each other, where ϳ200 l fluid was held by capillary forces. Micropipettes could access the chamber from its sides. RBCs were covalently linked with polyethylene glycol-biotin polymers, and pure glass beads, purchased at Bangs Labs (Fishers, IN, USA), were coated with streptavidin molecules following protocols kindly provided by Evan Evans. More details about these protocols can be read in Merkel et al. [38] . Afterwards, the beads were incubated for 3 min in a 0.5-g/ml PBS solution of biotinylated goat anti-human Fc antibody (Chemicon) in excess, rinsed two times at 13,000 g for 5 min, incubated for 2 min in a 0.2-g/ml PBS solution of P-sel-Fc chimera (R&D Systems), rinsed two times at 13,000 g for 5 min, and resuspended in DMEM medium. The P-sel coverage was adjusted so that 10 -20% of the approach separation cycles displayed an adhesion event. Some streptavidin-binding sites remained available for binding in sufficiently high density to attach the beads irreversibly to the RBC.
The theoretical shape of rupture force distributions at any given loading rate follows the following law [39, 40] 
, where a and b depend on the properties of the bonds. This distribution is not symmetrical. However, this predicted shape is never observed. Experimental distributions are much closer to Gaussian ones. The discrepancy between theory and experiments is a result of unavoidable experimental errors [40, 41] . The position of the peak of the distribution is not changed significantly by these experimental errors. As expected, we also observe almost Gaussian distribution in the present study (see Fig. 4A ). Although this is not perfectly rigorous, the small difference between the experimental distributions and Gaussian distributions makes it the best simple test available, and the drawn conclusions will remain correct.
Statistics
Statistics were carried out using GraphPad Prism v5.00 (GraphPad, San Diego, CA, USA). The percentage of adhesive cells (see Fig. 2 ), the proportion of adhesive events (see Fig. 3A ), and that of visco-elastic ruptures (see Fig. 3B ) in BFP, as well as the F*elast (see Fig. 4 ), were compared among groups by t-test. Spearman correlation coefficient was used for testing trend, according to the number of repeats of the VNTR.
RESULTS
Production of cells expressing the different haplotypic versions of PSGL-1
To explore the biophysical and adhering behavior of the PSGL-1 genetic variants in stably transfected cell lines, we first designed plasmid constructs including four versions of the complete human SELPLG ORF, which harbor the four main haplotypes existing in the Causasian population, combining three common polymorphisms (M62I; the VNTR with 14, 15, or 16 repeats; and S273F-M274V, respectively). These constructs were named M14V ("M" for methionine in position 62, "14" for 14 repeats of the VNTR, and "V" for Phe-Val in position 273-274), M15M ("M" for methionine in position 62, "15" for 15 repeats of the VNTR, and "M" for Ser-Met in position 273-274), and according to the same nomenclature, M16M and I16M. The frequencies of M14V, M15M, M16M, and I16M in Europeans were 0.02, 0.16, 0.74, and 0.08, respectively [20] . We transfected these different plasmids in a HEK cell line that harbors two copies of the most common 16 repeat haplotype but does not express PSGL-1 (data not shown). Moreover, HEK cells do not possess the complete post-translational system necessary for the correct modification of the PSGL-1 protein. So we treated the HEK line for a transfection cargo containing one of these PSGL-1-expressing constructs, the reporter pEYFP vector as a tracing vector, and the pEA.3/4FT encoding the 3/4FT necessary for the correct post-translational modification of PSGL-1 in HEK cells, as done previously [3] . Moreover, the HEK cell line contained the sulfation machinery [42, 43] required for high affinity of PSGL-1 for P-sel [44 -46] .
Stable cell lines expressing YFP and each isoform of PSGL-1 were obtained containing oligoclonal pools that were mostly positive for surface PSGL-1. These HEK pools were named M14V, M15M, M16M, and I16M and are at least 70% positive for PSGL-1 expression with similar mean fluorescence intensity (Fig. 1A) . As no selection marker was present on the transfected plasmid expressing the FT, we checked out by PCR that the four final pools actually expressed the enzyme. Finally, we verified by Western blotting that the sialyl Lewis X moiety was present and glycosylated correctly (fucosylated and sialylated) using the CHO-131 monoclonal [47] (data not shown). The correct PSGL-1 expression was confirmed further in the four pools by RT-PCR (data not shown) and by Western blotting (Fig. 1B) . All pools contained the 240-kDa and 120-kDa bands, corresponding to the homodimeric and monomeric isoforms of the protein, respectively, as usually observed [3, 48] .
Static adhesion
The four HEK pools expressing PSGL-1 were first assayed by adhesion to a P-sel-coated surface. As a preliminary assay, cells positive for YFP and PSGL-1 but not transfected with the FT were confirmed to be unable to adhere to the P-sel surface, and cells triply transfected could bind to P-sel, bearing out that the post-translational modification of PSGL-1 was an absolute requirement for binding to P-sel as reported already [3, 46] . The static adhesion assay was conducted to take into account only the YFP-positive cells to exclude the cells that do not express the PSGL-1 variant (see Materials and Methods). As shown in Figure 2 , each pool was adhering positively to the P-sel-coated surface (open bars), and they showed only background binding to an unspecific surface (shaded bars). When comparing M16M, M15M, and M14V cell lines, a negative trend between the adhesive potency of cells and the number of repeats was found (Spearman correlation coefficientϭ-0.62; Pϭ0.01; Fig. 2) . Moreover, the cells expressing I16M were found to adhere less frequently than the M16M ones (Pϭ0.04; Fig. 2 ), although they expressed PSGL-1 at a similar level (Fig. 1B) .
Adhesion of P-sel to PSGL-1 variants assayed by BFP
As the adhesion bond between P-sel and PSGL-1 was proven to behave as a catch bond [34] , we tested this property for our PSGL-1 cell pools by means of the BFP technique [37] using a RBC and a bead coated with P-sel molecules (Fig. 3A, inset; see also Materials and Methods). Using different loading rates, we first reported the probability of adhering events (Fig. 3A) . At loading rates of 130 and 300 pN/s, there was no significant difference between any cell line and the parental HEK cell line. At a loading rate of 700 pN/s, the frequency of adhesive events increased for all cell lines except for M16M. This increase was even more marked at 3000 pN/s for M14V and M15M cells (PϽ0.001 for each by comparison with HEK cells). This is typical of a catch bond behavior.
For each adhering event, the BFP technique allowed to display a force versus distance profile (Fig. 3B, inset) . Two cases could exist. The rupture could be obtained once after a linear rise in force: This is the elastic mode (Fig. 3B, inset, solid  line) . Alternatively, the rupture exhibited a two-step profile (nonlinear profile, Fig. 3B, inset, dotted line) . This visco-elastic mode probably reflects a viscous tether extrusion [35] . Both cases could occur, but their relative frequency might possibly differ among PSGL-1 variants. Figure 3B displays the proportion of visco-elastic ruptures among all rupture events, according to the different PSGL-1 variants. Overall, this proportion increased with increasing loading rates whatever the variant. At the two higher loading rates, the proportion of visco-elastic ruptures was approximately 40% in M16M. At these loading rates, the proportions of visco-elastic ruptures were higher in M15M and M14V variants, although the differences did not always reach statistical significance (Fig. 3B) . By contrast, the frequency of visco-elastic events never exceeded 30% for parental and I16M HEK cells.
The elastic mode of rupture
For the most frequent mode of rupture-the elastic one (solid arrow in Fig. 3B, inset )-an analysis of the level of the rupture force, according to the PSGL-1 variants, was performed in each condition. Assuming a Gaussian profile (see Materials and Methods), a diagram of different rupture forces was drawn (Fig. 4A) . The peak of this Gaussian distribution, i.e., the amplitude of the most frequent rupture force (F*elast), is reported in Figure 4B .
At both loading rates of 700 and 3000 pN/s, the rupture force in M14V, M15M, and M16M was significantly higher than the nonspecific one obtained with parental HEK (PϽ0.001 for each), confirming the catch bond behavior of these PSGL-1 variants (Fig. 4B) . Moreover, at both loading 
The visco-elastic mode of rupture
The same analysis was done for the visco-elastic mode of rupture. The diagram of rupture force (dotted arrow in Fig. 3B , inset) was built, and the most frequent rupture force (F*visc) was reported. Figure 4 , C and D (dotted bars), reports F*visc for the two higher loading rates (700 and 3000 pN/s, respectively). We observed the same significant trend as for the elastic mode, according to the number of repeats, reaching statistical difference at 3000 pN/s (Spearman correlation coefficientϭ-0.42; PϽ0.0001).
DISCUSSION
The goal of the present work was to analyze the adhesive characteristics of the various natural variants of the PSGL-1 molecule. Except the M16M one, these variants are relatively rare, and it would therefore be difficult to lead this study on primary cells. So, we generated HEK cell pools expressing the four natural PSGL-1 variants with similar surface expression levels (Fig. 1A) and with complete fucosylation, especially on the sialyl Lexis X moiety. Although our pools were not strictly clonal, we considered that the small variation in expression levels of PSGL-1 and of the FT among them was not affecting our results, as adhesion in static conditions and in BFP only works if PSGL-1 is modified correctly, post-translationally, according to our observation and preceding studies [3, 46] . (pN) for the M14V pool at the 3000 pN/s-loading rate. Note that a few events appear beyond the main peak of force, probably corresponding to multiple bonds. (B) Elastic rupture force F*, according to the loading rate for the various pools (Ϯsd). Each PSGL-1 variant was compared with the parental HEK at the same loading rate: ***, P Ͻ 0.001. The heavy dotted line shows the data issued from the report by Evans and co-workers [35] . (C) F*elast and F*visc, according to the parental HEK cell line and the various pools tested after BFP assay at a loading rate of 700 pN/s. (D) Same at a loading rate of 3000 pN/s. The relation between F*elast or F*visc and the number of repeats were tested using a nonparametric correlation test (***, PϽ0.0001). No F*visc is observed in the parental HEK cells. 
Adhesion characteristics of M14V and M15M by comparison with M16M
Our results showed that M14V and M15M cells behaved in a catch bond-type, as already shown for major PSGL-1 variants in primary cells [34] : At high loading rates (i.e., 700 pN/s or higher), the force of rupture increased with the loading rate, whereas it remained at an unspecific background level for low loading rates (i.e., 300 pN/s or below). This dramatic weakening of transient adhesion bonds between leukocytes and the endothelium under low shear stress is believed to prevent clogging in blood vessels, where flow is slow [34] .
At the high loading rate that we used (3000 pN/s), we found that the values of the elastic rupture force decreased significantly with the number of repeats of the VNTR (Fig. 4) . The same trend was also found using the static adhesion assay (Fig. 2) , indicating that the rupture force and hence, the adhesive potency were higher when the VNTR is lower.
Compared with M15M and M16M variants, the M14V naturally bears the double S273F-M274V mutations in the European population. Lozano et al. [21] observed that the M14V allele was binding less to platelets expressing P-sel. However, they used neutrophils from individuals heterozygous for M14V/M16M and compared them with homozygous wild-type (M16M) carriers. As a result of the low frequency of the M14V haplotype, homozygous carriers are indeed rare. The coexistence in a cell of the two variant proteins in equimolar proportions likely gives rise to different proteins, including "perfect homodimers", where the two PSGL-1 molecules are identical, and "variant heterodimers," where one monomer is shorter than the other. The stability of these molecules can be questioned because of the estimated gap of up to 50 Å between the two partners of the dimmer, and their behavior is potentially different from the one of strictly homodimeric proteins. Indeed, dimerization is known to stabilize PSGL-1 and to favor binding to P-sel [49, 50] . On the contrary, the cells that we used each expressed only a single isoform of PSGL-1. The measures we were able to do might reflect the most stable cases and might not apply to heterozygous carriers. So, we anticipate that most probably, the S273F-M274V mutations themselves do not affect the adhesive behavior of the M14V cells and that its better adhesive potency is a result of mainly its lower VNTR number.
PSGL-1 anchor to cytoskeleton
The PSGL-1 variants exhibited the elastic and the visco-elastic modes of ruptures, meaning that the P-sel-PSGL-1 bond disrupts before or after the extension of the cellular tether involved in the intercellular bond [51] . Two situations might happen: The P-sel-PSGL-1 bond is stronger than the cytoskeletal anchor, and in that case, most of the bonds are of the visco-elastic type, or the cytoskeletal anchor is stronger, and most of the bonds are of the elastic type. For the most frequent form of PSGL-1, M16M, the proportion of visco-elastic ruptures was approximately 40%, indicating that the link with P-sel was generally weaker than the PSGL-1 cytoskeletal anchoring. However, at higher loading rates, the proportion of visco-elastic rupture events increased in M15M and M14V variants by comparison with M16M (Fig. 4C) . This result suggests that a lower number of repeats in the SELPLG sequence tends to produce a stronger bond between PSGL-1 and P-sel, even stronger than its cytoskeletal anchorage to cytoskeleton.
We should stress that the nature of the anchor to cytoskeleton is not known. Although in vitro experiments in transfected cell lines showed that the truncation of the cytoplasmic domain impaired the adhesive properties of the P-sel-PSGL-1 couple [52] , in vivo studies in mice models proved that the ablation of this cytoplasmic tail did not alter the PSGL-1-dependent leukocyte rolling [53] . The PSGL-1 link to cytoskeleton could be indirect through other membrane proteins that partition into the same lipid raft, together with PSGL-1 [53] . The cellular distribution, clustering, and surface availability of PSGL-1 molecules seem indeed important parameters for an efficient adhesion to the opposite cellular partner [53] [54] [55] . Besides, we cannot rule out that the anchorage of PSGL-1 to the cytoskeleton is also affected by genetic polymorphisms.
Adhesion characteristics of M16M and I16M
I16M was adhering with a significantly lower potency than M16M in static (Fig. 2 ) and dynamic assays (Fig. 4) . As I16M and M16M only differ by the M62I mutation, our data suggest that this mutation was responsible for the lower adhering potency of the resulting PSGL-1 isoform. This effect is probably a result of the fact that the M62I mutation affects the last amino acid of the domain considered to be the P-sel-binding site [35, 45, 56] . Our result is the first evidence supporting a functional consequence of this mutation.
According to Figure 3A , it was not possible to bear out that the M16M bond to P-sel was of catch bond-type, as the frequency of positive adhesive events did not appear to increase with loading rates. However, we believe that it is most probably the case for two reasons: 1. In a previous study from Evans et al. [34] , it was shown that the PSGL-1-P-sel link was of catch bond-type. This study used primary neutrophils from individuals whose genotype was not specified, but these neutrophils were most likely to bear the most common variant of PSGL-1, i.e., the M16M one. 2. The elastic rupture forces, according to increasing loading rates, were significantly different from the nonspecific values obtained with the parental HEK cells (Fig.  4B ) and were strictly parallel to the values reported by Evans et al. [34] . Taking into account that HEK cells have a high frequency of nonspecific bonds and that the calibration of force measurements in our study could differ slightly from that used by Evans et al. [34] , our results are in agreement with those obtained by Evans et al. [34] using primary neutrophils.
Our work demonstrated that the M62I mutation of the SELPLG gene affected the adhesion of PSGL-1 to P-sel, the P-sel bonds with PSGL-1 are probably of catch bond-type, and the shorter the SELPLG VNTR stretch, the stronger the catch bond.
The hinge in interdomain regions of P-and L-selectins has been proven to be important in the catch bond behavior of their adhesion with PSGL-1 [57, 58] . Under moderate force, the selectin would be in an extended conformation, and a sliding-rebinding model has been proposed to account for catch bond [57] . Our present data indicate that the VNTR stretch in PSGL-1 could also be of importance. One could imagine that a longer VNTR domain could make the structure of PSGL-1 more flexible, inducing less-fit with P-sel epitopes during the rebinding step. Nevertheless, more studies are required to bear out the relevance of VNTR length in the adhesion of PSGL-1 to P-sel, since its truncation has no influence in its adhesive binding within L-selectin [57, 59] .
The VNTR is observed in all species and ranges from seven (pig) to 18 (chimp) repeats. Although epidemiological studies have reported some positive associations of the VNTR extension with cardiovascular and inflammatory diseases, it is difficult to find a convincing, reproducible association. This may be explained by the fact that end-points used in these studies are submitted to many confounding parameters. We analyzed previously the relationship between polymorphisms and plasma levels of PSGL-1 and showed that the M14V haplotype was associated with decreased levels of the circulating, soluble form [60] . This intermediate phenotype, more proximal to the gene than disease end-points, as myocardial infarction or CAD, might be easier to correlate to a particular allele of the coding gene. However, it is not clear how the polymorphisms of PSGL-1 might influence the release of the molecule in the circulation and how adhesion might be affected by this phenomenon.
In addition, although polymorphisms of PSGL-1 seem to have a clear impact on its expression levels [60] and its adhesive properties (the present study), it has to be noted that P-sel is also a highly polymorphic molecule with many nonsynonymous mutations affecting its coding sequence, and a soluble isoform resulting from alternative splicing [60] is observed. This variability is likely to affect its capacities as a receptor for PSGL-1 in the same way as polymorphisms affect PSGL-1 function and therefore, complicate the deciphering of an a priori simple receptor/ligand relationship.
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